Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41598-020-67514-4

http://scihub22266oqcxt.onion/10.1038/s41598-020-67514-4
suck pdf from google scholar
32606340!7327036!32606340
unlimited free pdf from europmc32606340    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32606340&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid32606340      Sci+Rep 2020 ; 10 (1): 10638
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models #MMPMID32606340
  • Nono JK; Fu K; Mpotje T; Varrone G; Aziz NA; Mosala P; Hlaka L; Kamdem SD; Xu D; Spangenberg T; Brombacher F
  • Sci Rep 2020[Jun]; 10 (1): 10638 PMID32606340show ga
  • Tissue fibrosis underlies the majority of human mortality to date with close to half of all reported deaths having a fibrotic etiology. The progression of fibrosis is very complex and reputed irreversible once established. Although some preventive options are being reported, therapeutic options are still scarce and in very high demand, given the rise of diseases linked to fibroproliferative disorders. Our work explored four platforms, complementarily, in order to screen preventive and therapeutic potentials of the antiparasitic drug Praziquantel as a possible antifibrotic. We applied the mouse CCl(4)-driven liver fibrosis model, the mouse chronic schistosomiasis liver fibrosis model, as well as novel 2D and 3D human cell-based co-culture of human hepatocytes, KCs (Kupffer cells), LECs (Liver Endothelial Cells), HSCs (Hepatic Stellate Cells) and/or myofibroblasts to mimic in vivo fibrotic responses and dynamics. Praziquantel showed some effect on fibrosis marker when preventively administered before severe establishment of fibrosis. However, it failed to potently reverse already established fibrosis. Together, we provided a novel sophisticated multi-assay screening platform to test preventive and therapeutic antifibrotic candidates. We further demonstrated a direct preventive potential of Praziquantel against the onset of fibrosis and the confirmation of its lack of therapeutic potential in reversing already established fibrosis.
  • |Animals[MESH]
  • |Antiparasitic Agents/pharmacology/*therapeutic use[MESH]
  • |Female[MESH]
  • |Hepatic Stellate Cells/drug effects[MESH]
  • |Hepatocytes/drug effects[MESH]
  • |Kupffer Cells/drug effects[MESH]
  • |Liver Cirrhosis/*drug therapy/etiology[MESH]
  • |Male[MESH]
  • |Mice[MESH]
  • |Mice, Inbred BALB C[MESH]
  • |Myofibroblasts/drug effects[MESH]
  • |Praziquantel/pharmacology/*therapeutic use[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box